Scarica l'app Stockscreener
78.79
1.83%
-1.47
Dopo l'orario di chiusura:
78.79
Precedente Chiudi:
$80.26
Aprire:
$79.41
Volume 24 ore:
834.62K
Relative Volume:
0.47
Capitalizzazione di mercato:
$10.70B
Reddito:
$3.10B
Utile/perdita netta:
$586.71M
Rapporto P/E:
18.35
EPS:
4.2937
Flusso di cassa netto:
$605.57M
1 W Prestazione:
+3.01%
1M Prestazione:
-0.28%
6M Prestazione:
-13.11%
1 anno Prestazione:
+49.71%
Intervallo 1D:
$77.14
$79.58
Intervallo di 1 settimana:
$75.72
$81.79
Portata 52W:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Nome
Globus Medical Inc
Settore
Industria
Telefono
610-930-1800
Indirizzo
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
78.79 | 10.62B | 3.10B | 586.71M | 605.57M | 4.2937 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Aggiornamento | Needham | Hold → Buy |
| 2026-01-27 | Iniziato | TD Cowen | Buy |
| 2025-11-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-11-07 | Aggiornamento | Truist | Hold → Buy |
| 2025-10-28 | Ripresa | Stifel | Hold |
| 2025-05-27 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-01-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-19 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-30 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-02-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-02-10 | Downgrade | Loop Capital | Buy → Hold |
| 2023-02-10 | Downgrade | Needham | Buy → Hold |
| 2023-02-10 | Downgrade | Truist | Buy → Hold |
| 2023-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-28 | Iniziato | Wells Fargo | Overweight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-29 | Iniziato | Loop Capital | Buy |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2020-12-08 | Iniziato | Citigroup | Buy |
| 2020-10-20 | Iniziato | Stifel | Hold |
| 2020-08-06 | Reiterato | Needham | Buy |
| 2020-08-06 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Iniziato | Northland Capital | Market Perform |
| 2020-07-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Reiterato | Needham | Buy |
| 2020-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-12-12 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Reiterato | Needham | Buy |
| 2019-05-24 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Reiterato | Needham | Buy |
| 2019-02-28 | Aggiornamento | UBS | Neutral → Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-27 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Reiterato | Needham | Buy |
| 2018-04-04 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Globus Medical Inc Borsa (GMED) Ultime notizie
Globus Medical Inc (GMED) Balance Sheet - TradingKey
Globus Medical Inc (GMED) Cash Flow - TradingKey
Globus Medical Inc (GMED) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GMED|Globus Medical Inc|Price:78.225|Chg%:+1.735 - TradingKey
Globus Medical Inc (GMED) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Globus Medical | SCHEDULE 13G: Others - Moomoo
Globus Medical Inc (GMED) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Globus Medical Inc Class A Revenue Breakdown – DUS:GM0N - TradingView
Globus Medical Inc Class A Revenue Breakdown – TRADEGATE:GM0N - TradingView
Globus Medical Inc (GMED) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GMED Growth Drivers After NuVasive and What Q1 Signals - qz.com
Fed. Circ. Panel Stands By Invalidated Spinal Fusion IP - Law360
Reasons to Retain Globus Medical Stock in Your Portfolio for Now - Zacks Investment Research
ETFs Investing in Globus Medical Inc Class A Stocks - TradingView
3 Medical Device Stocks Giving Investors a Different Healthcare Play - MarketBeat
Globus Medical Drops 5.6% After Truist Securities Maintains Buy - AlphaStreet
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know - Yahoo Finance
Globus Medical Inc (GMED) Stock Down 4.8% -- Now Undervalued? GF Score: 96/100 - GuruFocus
GMED Stock Surges 43.6% in a Year: What's Driving the Rally? - TradingView
Press Release: Globus Medical Schedules Second Quarter Earnings Release and Conference Call - Moomoo
Law firm probes Globus Medical officers for pos... - Pluang
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm - Carroll County Mirror-Democrat
Globus Medical to announce Q2 results on August 6 - scanx.trade
Globus Medical to Announce Second Quarter 2026 Financial Results on August 6 - Moomoo
Globus Medical Sets Aug. 6 Call on Second-Quarter Results - Stock Titan
Globus Medical Is Maintained at Buy by Truist Securities - Moomoo
Truist Financial Maintains Globus Medical(GMED.US) With Buy Rating, Announces Target Price $100 - Moomoo
Truist Adjusts Price Target on Globus Medical to $100 From $115, Maintains Buy Rating - marketscreener.com
Globus Medical (GMED) Stock Still Looks Undervalued Despite A 39% Return - Yahoo Finance
David Paul - Forbes
Globus Medical Inc (GMED) Stock Down 4.9% -- Now Undervalued? GF Score: 97/100 - GuruFocus
Globus Medical (GMED) Falls as Recent Analyst Caution Appears to Weigh on Shares - Quiver Quantitative
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Cuts Target Price to $115 - Moomoo
RBC Lowers Price Target on Globus Medical to $115 From $120, Keeps Outperform Rating - marketscreener.com
Barclays Maintains Globus Medical (GMED) Overweight Recommendation - MSN
Is Globus Medical (GMED) Undervalued Or Is Its Robotics Growth Already Priced In? - simplywall.st
Centralization Of Cases Against Additional Spinal Cord Device Manufacturers Sought - Mealey's
GMED stock holds steady on Globus Medical's business profile - Ad-hoc-news.de
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? - TradingView
Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGR - GlobeNewswire Inc.
Globus Medical IncA (NYSE:GMED) Screens Well as a GARP Stock with Strong Growth and Reasonable Valuation - ChartMill
BMO Capital Maintains Globus Medical(GMED.US) With Buy Rating, Cuts Target Price to $94 - Moomoo
Intuitive, Globus, Teleflex named top picks as BMO initiates MedTech on buying opportunity - Seeking Alpha
BMO Capital Initiates Globus Medical at Outperform With $94 Price Target - marketscreener.com
Stifel Maintains Globus Medical(GMED.US) With Hold Rating, Cuts Target Price to $80 - Moomoo
A Look at Globus Medical Inc (GMED) After 3.3% Decline -- GF Val - GuruFocus
Globus Medical (GMED) Receives Positive Coverage from BMO Capita - GuruFocus
Stifel cuts Globus Medical stock price target on growth concerns By Investing.com - Investing.com Australia
Stifel cuts Globus Medical stock price target on growth concerns - Investing.com
Globus Medical (GMED) Rose With Device Stocks, Is It Still 27% Undervalued? - Yahoo Finance
Globus Medical Inc focuses on spine technologies as investors watch long term growth - ad-hoc-news.de
Globus Medical Inc Azioni (GMED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Globus Medical Inc Azioni (GMED) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Davidar David D | Director |
Jun 05 '26 |
Sale |
80.76 |
25,000 |
2,019,072 |
510,175 |
| RHOADS ANN D | Director |
Jun 04 '26 |
Option Exercise |
26.27 |
25,000 |
656,750 |
40,384 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):